U.S. markets closed

Zymergen Inc. (ZY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
31.92+3.42 (+12.00%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close28.50
Open29.99
Bid30.01 x 1000
Ask31.92 x 1200
Day's Range29.60 - 32.16
52 Week Range25.75 - 52.00
Volume375,010
Avg. Volume853,035
Market Cap3.126B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Zymergen to Report First Quarter 2021 Financial Results on May 24, 2021
      GlobeNewswire

      Zymergen to Report First Quarter 2021 Financial Results on May 24, 2021

      EMERYVILLE, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen, today announced it will report financial results for the first quarter 2021 after market close on Monday, May 24th, 2021. The company’s management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. A webcast of the conference call can be accessed at https://investors.zymergen.com/. The webcast will be archived and available for replay for at least 90 days after the event. About Zymergen Zymergen is a biofacturing company using biology to reimagine the world. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials. Investor ContactNiraj Javeriinvestors@zymergen.com Media ContactMike Dulinmdulin@zymergen.com502-777-2029

    • Zymergen Hires Former Apple Executive and Ford Motor Leader as Chief Manufacturing Officer
      PR Newswire

      Zymergen Hires Former Apple Executive and Ford Motor Leader as Chief Manufacturing Officer

      Biofacturing leader Zymergen (Nasdaq: ZY) today announced Aindrea Campbell is joining the company as Chief Manufacturing Officer, developing and leading Zymergen's global manufacturing and supply chain activities.

    • 2 Risky Life-Sciences Stocks to Avoid and 1 to Buy Now
      Motley Fool

      2 Risky Life-Sciences Stocks to Avoid and 1 to Buy Now

      Enthusiasm for life-sciences stocks may be at an all-time high, but it's easy to lose your shirt when dealing with companies on the cutting edge like Calyxt (NASDAQ: CLXT) and Zymergen (NASDAQ: ZY). Both of these companies have huge potential for growth, but investors probably want to watch them from a safe distance for now. After discussing what to avoid, I'll also show you why Thermo Fisher Scientific (NYSE: TMO) is one of the best life-sciences stocks you can buy now.